Prediction of chemotherapeutic response in ovarian cancer with DNA microarray expression profiling

Cancer Genetics and Cytogenetics
Zachariah E SelvanayagamKhew-Voon Chin

Abstract

Ovarian carcinoma is a leading cause of gynecologic cancer death in women. Despite treatment, a large number of women with ovarian cancer eventually relapse and die of the disease. Hence, recurrent ovarian cancer continues to be a therapeutic dilemma, possibly a result of the emergence of drug resistance during relapse. Recent advances in expression genomics enable global transcript analysis that leads to molecular classification of cancers and prediction of outcome and treatment response. We did a cDNA microarray examination of the expression profiles of eight primary ovarian cancers stratified into two groups based on their chemotherapeutic response. We applied a voice-speech-pattern recognition algorithm for microarray data analysis and were able to model and predict the response of these patients to chemotherapy from their expression profiles. Hence, gene expression profiling by means of DNA microarray may be applied diagnostically for predicting treatment response in ovarian cancer.

References

Aug 1, 1989·British Journal of Obstetrics and Gynaecology·J H Shepherd
Aug 30, 2000·Nature·C M PerouD Botstein
Feb 7, 2001·Proceedings of the National Academy of Sciences of the United States of America·J B WelshG M Hampton
Feb 24, 2001·The New England Journal of Medicine·I HedenfalkG Sauter
Jun 30, 2001·The New England Journal of Medicine·O I Olopade, T Grushko
Sep 13, 2001·Proceedings of the National Academy of Sciences of the United States of America·T SørlieA L Børresen-Dale
Feb 2, 2002·Nature·Laura J van 't VeerStephen H Friend
Jul 16, 2002·Nature Medicine·David G BeerSamir Hanash
Sep 19, 2002·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Jin Q ChengBenjamin K Tsang
Dec 20, 2002·The New England Journal of Medicine·Marc J van de VijverRené Bernards
Jun 6, 2003·The New England Journal of Medicine·Richard Wooster, Barbara L Weber
Jul 2, 2003·Nature Reviews. Cancer·Roshan Agarwal, Stan B Kaye
Aug 9, 2003·The New England Journal of Medicine·Ellen Wright Clayton

❮ Previous
Next ❯

Citations

Mar 7, 2006·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·A P G CrijnsE G E de Vries
Jan 26, 2008·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·B GyörffyH Lage
Jun 17, 2006·The Tohoku Journal of Experimental Medicine·Shori AbeTakeshi Sasaki
Oct 4, 2012·Future Oncology·Klaus H BaumannAndreas du Bois
Mar 3, 2009·Critical Reviews in Oncology/hematology·Renaud SabatierFrançois Bertucci
May 27, 2008·Endocrinology and Metabolism Clinics of North America·Thomas J Giordano
Apr 22, 2008·Annales d'endocrinologie·T J Giordano
Aug 23, 2011·International Journal of Cancer. Journal International Du Cancer·Tibor FeketeBalázs Györffy
Dec 17, 2009·The Mount Sinai Journal of Medicine, New York·Analisa DiFeoJohn A Martignetti
Oct 24, 2006·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·R I OlivierL J van' t Veer
Oct 20, 2005·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Alan Richardson, Stan B Kaye
Jun 5, 2007·BMC Genomics·Ashleen ShadeoCalum MacAulay
Oct 17, 2009·BMC Cancer·Thangarajan RajkumarLavanya Nambaru
Oct 27, 2009·The International Journal of Biochemistry & Cell Biology·Jozien HellemanEls M J J Berns
Apr 18, 2015·BMC Cancer·Katherine L LloydRichard S Savage
Oct 4, 2011·Journal of Proteomics·Xin-Hui LiZhi-Qiang Xiao
Oct 2, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·John D MinnaYang Xie
Sep 15, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Norbert AvrilWalther Kuhn
Jul 24, 2008·Nature Clinical Practice. Oncology·Panagiotis A KonstantinopoulosStephen A Cannistra
Jul 25, 2009·Obstetrical & Gynecological Survey·Vanessa N HarryDavid E Parkin
Oct 14, 2009·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Kirsten M JochumsenOle Mogensen
Mar 25, 2006·International Journal of Cancer. Journal International Du Cancer·Tanya R NewtonGlen M Boyle
Jan 29, 2011·Cancer Control : Journal of the Moffitt Cancer Center·Hye Sook Chon, Johnathan M Lancaster
Mar 10, 2021·Scientific Reports·Douglas V N P OliveiraEstrid V Høgdall
Jan 24, 2008·Molecular Cancer·Alexandros LaiosJohn J O' Leary

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Genomics (Keystone)

Cancer genomics approaches employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research using such technologies in this feed.

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.

Related Papers

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Dimitrios SpentzosStephen A Cannistra
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
Amir A JazaeriJeff Boyd
International Journal of Cancer. Journal International Du Cancer
Jozien HellemanEls M J J Berns
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
Lynn C HartmannAndrew I Damokosh
© 2021 Meta ULC. All rights reserved